randomly assigned 55 patients with biopsy-confirmed NASH and either impaired glucose tolerance or type 2 diabetes to receive a hypocaloric diet plus either pioglitazone (30 mg daily for 2 months ...
Participants were randomly allocated to 16 weeks of either active (pioglitazone 30 mg daily) or placebo treatment. One woman in each group withdrew (one pregnancy and one adverse reaction to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback